medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2017, Número 6

<< Anterior Siguiente >>

Ann Hepatol 2017; 16 (6)


Analysis of the MELD Score Impact in the Outcome of Endovascular Portal Vein Reconstruction

Torres-Machorro A, Guerrero-Hernandez M, Anaya-Ayala JE, Torre A, Laparra-Escareno H, Cuen-Ojeda C, Garcia-Alva R, Hinojosa CA

Idioma: Ingles.
Referencias bibliográficas: 42
Paginas: 950-958
Archivo PDF: 292.53 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. DeLeve LD, Valla DC, Garcia-Tsao G; American Association for the Study Liver Diseases. Vascular disorders of the liver. Hepatology 2009; 49: 1729-64. doi: 10.1002/ hep.22772. No abstract available.

  2. Amitrano L, Guardascione MA, Brancaccio V, Margaglione M, Manguso F, Iannaccone L, Grandone E, Balzano A. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol 2004; 40(5): 736-41.

  3. Ogren M, Bergqvist D, Björck M, Acosta S, Eriksson H, Sternby NH. Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies. World J Gastroenterol 2006; 12(13): 2115-9.

  4. Amitrano L, Guardascione MA, Brancaccio V, Margaglione M, Manguso F, Iannaccone L, Grandone E, et al. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol 2004; 40: 736-41.

  5. Belli L, Romani F, Sansalone CV, Aseni P, Rondinara G. Portal thrombosis in cirrhotics. A retrospective analysis. Ann Surg 1986; 203: 286-91.

  6. [No authors listed] A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators. Hepatology 1998; 28: 751-5.

  7. Pirisi M, Avellini C, Fabris C, Scott C, Bardus P, Soardo G, Beltrami CA, et al. Portal vein thrombosis in hepatocellular carcinoma: age and sex distribution in an autopsy study. J Cancer Res Clin Oncol 1998; 124: 397-400.

  8. Plessier A, Darwish-Murad S, Hernandez-Guerra M, Consigny Y, Fabris F, Trebicka J, Heller J, et al. Europian Network for Vascular Disorders of the Liver (EN-Vie). Acute portal vein thrombosis unre-lated to cirrosis; a prospective multicenter folloup study. Hepatology 2010; 51(1): 210-8.

  9. Nonami T, Yokoyama I, Iwatsuki S, Starzl TE. The incidence of portal vein thrombosis at liver transplantation. Hepatology 1992; 16: 1195-8.

  10. Subramanyam BR, Balthazar EJ, Lefleur RS, Horii SC, Hulnick DH. Portal venous thrombosis: correlative analysis of sonography, CT and angiography. Am J Gastroenterol 1984; 79: 773-6.

  11. Englesbe MJ, Kubus J, Muhammad W, Sonnenday CJ, Welling T, Punch JD, Lynch RJ, et al. Portal vein thrombosis and survival in patients with cirrhosis. Liver Transpl 2010; 16: 83-90. doi: 10.1002/lt.21941

  12. European Association For The Study Of The Liver, European Organisation For Research And Treatment Of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012; 56: 908-43.

  13. Plessier A, Darwish-Murad S, Hernandez-Guerra M, Consigny Y, Fabris F, Trebicka J, Heller J, et al. Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study. Hepatology 2010; 51: 210-8.

  14. Condat B, Pessione F, Helene Denninger M, Hillaire S, Valla D. Recent portal or mesenteric venous thrombosis: increased recognition and frequent recanalization on anticoagulant therapy. Hepatology 2000; 32:466-70.

  15. Senzolo M, Sartori T, Rossetto V, Burra P, Cillo U, Boccagni P, Gasparini D, et al. Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis. Liver Int 2012; 32: 919-27.

  16. Causey MW, Nelson D, Johnson EK, Maykel J, Davis B, Rivadeneira DE, Champagne B, et al. The impact of Model of End-Stage Liver Disease-Na in predicting morbidity and Mortality following elective colon cancer surgery irrespective of underlying liver disease. Am J Surg 2014; 207(4): 520-6.

  17. Northup PG, Wanamaker RC, Lee VD, Adams RB, Berg CL. Model for End-Stage Liver Disease (MELD) predicts nontransplant surgical mortality in patients with cirrhosis. Ann Surg 2005; 242(2): 244-51.

  18. Lange EO, Jensen CC, Melton GB, Madoff RD, Kwaan MR. Relationship between model for end-stage liver disease score and 30-day outcomes for patients undergoing elective colorectal resections: an American college of surgeons- national surgical quality improvement program study. Dis Colon Rectum 2015; 58: 494-501.

  19. Elnahas A, Nguyen GC, Okrainec A, Quereshy F, Jackson TD. The effect of underlying liver disease on short-term outcomes following bariatric surgery. Surg Endosc 2014; 28: 2708-12. doi: 10.1007/s00464-014-3532-8.

  20. Morimoto N, Okada K, Okita Y. The model for end-stage liver disease (MELD) predicts early and late outcomes of cardiovascular operations in patients with liver cirrhosis. Ann Thorac Surg 2013; 96: 1672-8.

  21. Farnsworth N, Fagan SP, Berger DH, Awad SS. Child-Turcotte- Pugh versus MELD score as a predictor of outcome after elective and emergent surgery in cirrhotic patients. Am J Surg 2004; 188: 580-3.

  22. Luca A, Miraglia R, Caruso S, Milazzo M, Sapere C, Maruzzelli L, Vizzini G, et al. Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis. Gut 2011; 60(6): 846-52.

  23. Qi X, Han G, Yin Z, He C, Wang J, Guo W, Niu J, et al. Transjugular intrahepatic portosystemic shunt for portal cavernoma with symptomatic portal hypertension in noncirrhotic patients. Dig Dis Sci 2012; 57: 1072-82.

  24. Salem R, Vouche M, Baker T, Herrero JI, Caicedo JC, Fryer J, Hickey R, et al. Pretransplant Portal Vein Recanalization- Transjugular Intrahepatic Portosystemic Shunt in Patients With Complete Obliterative Portal Vein Thrombosis. Transplantation 2015; 99: 2347-55.

  25. Habib A, Desai K, Hickey R, Thornburg B, Vouche M, Vogelzang RL. Portal vein recanalization-transjugularintrahepatic portosystemic shunt using the transsplenic approach to achieve transplant candidacy in patients with chronic portal vein thrombosis. J Vasc Interv Radiol 2015; 26: 499-506.

  26. Chen Y, Ye P, Li Y, Ma S, Zhao J, Zeng Q. Percutaneous transhepatic balloon-assisted transjugular intrahepatic portosystemic shunt for chronic, totally occluded, portal vein thrombosis with symptomatic portal hypertension: procedure technique, safety, and clinical applications. Eur Radiol 2015; 25: 3431-7. doi: 10.1007/s00330-015-3777-1.

  27. Guerrero-Hernandez M, Hinojosa CA, Anaya-Ayala JE, Elenes E, Torre A. Endovascular Reconstruction of Extrahepatic Portal Vein in Noncirrhotic and Nonmalignant Chronic Portal Vein Thrombosis Secondary to an Iatrogenic Stenotic Lesion. Vasc Endovascular Surg 2016; 50(8): 559-62.

  28. Ko GY, Sung KB, Yoon HK, Kim JH, Song HY, Seo TS, Lee SG. Endovascular treatment of hepatic venous outflow obstruction after living-donor liver transplantation. J Vasc Interv Radiol 2002; 13(6): 591-9.

  29. Hanje AJ, Patel T. Preoperative evaluation of patients with liver disease. Nat Clin Pract Gastroenterol Hepatol 2007; 4: 266-76.

  30. Han G, Qi X, He C, Yin Z, Wang J, Xia J, Yang Z, et al. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis. J Hepatol 2011; 54: 78-88. doi: 10.1016/ j.jhep.2010.06.029.

  31. Senzolo M, Burra P, Patch D, Burroughs AK. Tips for portal vein thrombosis (pvt) in cirrhosis: not only unblocking a pipe. J Hepatol 2011; 55: 945-6.

  32. Ferral H, Gamboa P, Postoak DW, Albernaz VS, Young CR, Speeg KV, McMahan CA. Survival after elective transjugular intrahepatic portosystemic shunt creation: prediction with model for end-stage liver disease score. Radiology 2004; 231: 231-6.

  33. Chu HH, Kim HC, Jae HJ, Yi NJ, Lee KW, Suh KS, Chung JW, et al. Percutaneous transsplenic access to the portal vein for management of vascular complication in patients with chronic liver disease. Cardiovasc Intervent Radiol 2012; 35: 1388-95. doi: 10.1007/s00270-011-0311-y.

  34. Cao G, Ko GY, Sung KB, Yoon HK, Gwon DI, Kim JH. Treatment of postoperative main portal vein and superior mesenteric vein thrombosis with balloon angioplasty and/ or stent placement. Acta Radiol 2013; 54: 526-32. doi: 10.1177/0284185113475917.

  35. Krafcik BM, Farber A, Eslami MH, Kalish JA, Rybin D, Doros G, Shah NK, et al. The role of Model for End-Stage Liver Disease (MELD) score in predicting outcomes for lower extremity bypass. J Vasc Surg 2016; 64: 124-30.

  36. Perarnau JM, Baju A, D’alteroche L, Viguier J, Ayoub J. Feasibility and long-term evolution of TIPS in cirrhotic patients with portal thrombosis. Eur J Gastroenterol Hepatol 2010; 22(9): 1093-8. doi: 10.1097/ MEG.0b013e328338d995.

  37. Walser EM, NcNees SW, DeLa Pena O, Crow WN, Morgan RA, Solo-way R, Broughan T. Portal venous thrombosis: percutaneous therapy and outcome. J Vasc Interv Radiol 1998; 9: 119-27.

  38. Lai EC, Mok FP, Fan ST, Lo CM, Chu KM, Liu CL, Wong J. Preoperative endoscopic drainage for malignant obstructive jaundice. Br J Surg 1994; 81: 1195-8.

  39. Bauer J, Johnson S, Durham J, Ludkowski M, Trotter J, Bak T, Wachs M. The role of TIPS for portal vein patency in liver transplant patients with portal vein thrombosis. Liver Transpl 2006; 12: 1544-51.

  40. Luca A, Miraglia R, Caruso S, Milazzo M, Sapere C, Maruzzelli L, Vizzini G, et al. Short- and long-term effects of the transjugular in-trahepatic portosystemic shunt on portal vein thrombosis in pa-tients with cirrhosis. Gut 2011; 60: 846-52. doi: 10.1136/gut.2010.228023

  41. Senzolo M, Tibbals J, Cholongitas E, Triantos CK, Burroughs AK, Patch D. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation. Aliment Pharmacol Ther 2006; 23: 767-75.

  42. Paskonis M, Jurgaitis J, Mehrabi A, Kashfi A, Fonouni H, Strupas K, Büchler MW, et al. Surgical strategies for liver transplantation in the case of portal vein thrombosis-current role of cavoportal hemitransposition and renoportal anastomosis. Clin Transplant 2006; 20(5): 551-62.




2020     |     www.medigraphic.com